Page last updated: 2024-10-31

metoclopramide and Fatigue Syndrome, Chronic

metoclopramide has been researched along with Fatigue Syndrome, Chronic in 1 studies

Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.

Fatigue Syndrome, Chronic: A syndrome characterized by persistent or recurrent fatigue, diffuse musculoskeletal pain, sleep disturbances, and subjective cognitive impairment of 6 months duration or longer. Symptoms are not caused by ongoing exertion; are not relieved by rest; and result in a substantial reduction of previous levels of occupational, educational, social, or personal activities. Minor alterations of immune, neuroendocrine, and autonomic function may be associated with this syndrome. There is also considerable overlap between this condition and FIBROMYALGIA. (From Semin Neurol 1998;18(2):237-42; Ann Intern Med 1994 Dec 15;121(12): 953-9)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bruera, E1
Moyano, JR1
Sala, R1
Rico, MA1
Bosnjak, S1
Bertolino, M1
Willey, J1
Strasser, F1
Palmer, JL1

Trials

1 trial available for metoclopramide and Fatigue Syndrome, Chronic

ArticleYear
Dexamethasone in addition to metoclopramide for chronic nausea in patients with advanced cancer: a randomized controlled trial.
    Journal of pain and symptom management, 2004, Volume: 28, Issue:4

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antiemetics; Chronic Disease; Dexamethasone; D

2004